1. Home
  2. Age-Related Macular Degeneration (ARMD) Doctors Near Me
  3. Clinical Trials
  4. Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study

Age-Related Macular Degeneration (ARMD) Clinical Trials

Find Age-Related Macular Degeneration (ARMD) Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The purpose of this research study is to evaluate a new screening procedure for the early detection and monitoring of Age-related Macular Degeneration (AMD) in community settings and community hospital settings, to identify associated risk factors, and develop personalized monitoring strategies for at-risk individuals throughout the 5 years follow up period, which will allow us to establish prevalence, natural history of progression of early AMD in the community.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
View:

• Adults aged 55 years or older

• No severe systemic illnesses that prevent study participation

• Willing and able to undergo protocol-required procedures for both eyes

• Willing and able to provide written informed consent

Locations
Other Locations
Singapore
Outram Community Hospital
RECRUITING
Singapore
Singapore National Eye Centre/ Singapore Eye Research Institute
RECRUITING
Singapore
Contact Information
Primary
Gemmy Cheung Professor
gemmy.cheung.c.m@singhealth.com.sg
+6563224500
Time Frame
Start Date: 2025-10-18
Estimated Completion Date: 2029-07-31
Participants
Target number of participants: 1500
Related Therapeutic Areas
Late-Onset Retinal Degeneration
Age-Related Macular Degeneration (ARMD)
Sponsors
Leads: Singapore National Eye Centre
Collaborators: Singapore Health Services

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression in a Prospective, Multinational, Multicentre Observational Study

Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression in a Prospective, Multinational, Multicentre Observational Study

Enrollment Status: Recruiting
Publish Date: May 15, 2025

Progression of Early Atrophic Lesions in Age-related Macular Degeneration (AMD).

Progression of Early Atrophic Lesions in Age-related Macular Degeneration (AMD).

Enrollment Status: Recruiting
Publish Date: March 11, 2026
Intervention Type: Other

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics: A Randomized Controlled Clinical Trial

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics: A Randomized Controlled Clinical Trial

Enrollment Status: Recruiting
Publish Date: November 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved